US Stock MarketDetailed Quotes

CSLLY CSL LTD SPON ADR EACH REPR 0.5 ORD

Watchlist
  • 93.880
  • +1.570+1.70%
Close Mar 27 16:00 ET
90.74BMarket Cap36.89P/E (TTM)

About CSL LTD SPON ADR EACH REPR 0.5 ORD Company

CSL Ltd. is a biopharmaceutical company, which engages in the manufacture, marketing, and distribution of biopharmaceutical and allied products. It operates through the following segments: CSL Behring, CSL Seqirus, and CSL Vifor. The CSL Behring segment provides plasma products, gene therapies, and recombinants. The CSL Seqirus segment includes predominantly influenza related products and provides pandemic services to governments. The CSL Vidor segment focuses on the distribution of products in the therapeutic areas of iron deficiency and nephrology. The company was founded on November 2, 1961 and is headquartered in Melbourne, Australia.

Company Profile

SymbolCSLLY
Company NameCSL LTD SPON ADR EACH REPR 0.5 ORD
Founded1961
CEODr. Paul McKenzie
MarketPink Market
Employees32000
Securities TypeOrdinary Shares
Fiscal Year Ends06-30
Address655 Elizabeth Street
CityMelbourne
ProvinceVictoria (VIC)
CountryAustralia
Zip Code3000
Phone61-3-9389-1911

Company Executives

  • Name
  • Position
  • Salary
  • Dr. Paul McKenzie
  • Director, Managing Director and Chief Executive Officer
  • --
  • Dr. Brian A. Mcnamee
  • Chairman of the Board
  • --
  • Professor Andrew Cuthbertson, PhD
  • Director
  • --
  • Carolyn Hewson
  • Independent Director
  • --
  • Bruce R Brook
  • Independent Director
  • --
  • Professor Duncan Maskell, PhD
  • Independent Director
  • --
  • Dr. Megan Clark
  • Independent Director
  • --
  • Alison Mary Watkins
  • Independent Director
  • --
  • Marie McDonald
  • Independent Director
  • --

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg